Trend Following
(11)
▼
Momentum
(6)
▼
Volatility
(5)
▼
Pattern Recognition
(5)
▼
Mean Reversion
(4)
▼
Volume Based
(5)
▼
Advanced
(10)
▼
SINT
$2.97
$
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Next Earnings
2026-02-25
Beta
0.67
Average Volume
Market Cap
Last Dividend
CIK
0001269026
ISIN
US8293927039
CUSIP
829392307
CEO
Eric K. Olson
Sector
Healthcare
Industry
Medical - Devices
Full Time Employees
20
IPO Date
2014-02-13
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms | Appointment supports acceleration of revenue opportunities from SiNERGY ™ silicon nitride devices and antipathogenic fibrous material technologies | GlobeNewsWire | 2026-02-18 08:30:00 |
| SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5 | SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announced that its management team will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference, to be held February 4–5, 2026. | GlobeNewsWire | 2026-01-29 09:00:00 |
| Analyzing LivaNova (NASDAQ:LIVN) & Sintx Technologies (NASDAQ:SINT) | Sintx Technologies (NASDAQ: SINT - Get Free Report) and LivaNova (NASDAQ: LIVN - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability. Institutional and Insider Ownership 18.4% of Sintx Technologies shares | Defense World | 2025-12-12 02:26:44 |
| SINTX Technologies to Participate in Sidoti & Company Investor Conference | SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), today announced that management will be presenting at Sidoti and Company's Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P. M. | Globe News Wire | 2025-12-08 09:00:00 |
| SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants | Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company, today announced that it has signed a supply agreement with Evonik Corporation (“EVONIK”), a global leader in high‑performance polymers, to manufacture the Company's proprietary silicon nitride–PEEK compound (SiN/PEEK) (U.S. Patent No. 10,806,831) engineered for AI‑assisted additive manufacturing of patient‑specific implants that will be produced using equipment already in place at SINTX's U.S.-based production facility. | GlobeNewsWire | 2025-12-01 08:30:00 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| 4 | 2026-02-19 | 2026-02-19 | View Filing |
| 8-K | 2026-02-18 | 2026-02-18 | View Filing |
| 4 | 2026-02-10 | 2026-02-10 | View Filing |
| 4 | 2026-02-10 | 2026-02-10 | View Filing |
| 4 | 2026-02-10 | 2026-02-10 | View Filing |
| EFFECT | 2025-12-11 | 2025-12-12 | View Filing |
| S-3/A | 2025-12-09 | 2025-12-09 | View Filing |
| SC 13G | 2025-12-09 | 2025-12-09 | View Filing |
| 4 | 2025-12-09 | 2025-12-09 | View Filing |
| 4 | 2025-12-08 | 2025-12-08 | View Filing |
| 8-K | 2025-12-01 | 2025-12-01 | View Filing |
| SC 13G | 2025-11-14 | 2025-11-14 | View Filing |
| SC 13G/A | 2025-11-14 | 2025-11-14 | View Filing |
| 8-K | 2025-11-13 | 2025-11-13 | View Filing |
| 10-Q | 2025-11-12 | 2025-11-12 | View Filing |
| 4 | 2025-11-10 | 2025-11-10 | View Filing |
| S-3 | 2025-10-23 | 2025-10-23 | View Filing |
| 4 | 2025-10-21 | 2025-10-21 | View Filing |
| 8-K | 2025-10-03 | 2025-10-03 | View Filing |
| 424B5 | 2025-10-03 | 2025-10-03 | View Filing |
| S-8 | 2025-09-30 | 2025-09-30 | View Filing |
| S-3 | 2025-09-30 | 2025-09-30 | View Filing |
| 8-K | 2025-09-09 | 2025-09-09 | View Filing |
| 4 | 2025-09-05 | 2025-09-05 | View Filing |
| 3 | 2025-09-05 | 2025-09-05 | View Filing |
| 8-K | 2025-09-05 | 2025-09-05 | View Filing |
| SC 13G | 2025-09-03 | 2025-09-03 | View Filing |
| 4 | 2025-08-27 | 2025-08-27 | View Filing |
| 4 | 2025-08-27 | 2025-08-27 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 10-Q | 2025-08-14 | 2025-08-14 | View Filing |
| DEF 14A | 2025-07-31 | 2025-07-31 | View Filing |
| 8-K | 2025-07-22 | 2025-07-22 | View Filing |
| SC 13G | 2025-07-03 | 2025-07-03 | View Filing |
| 8-K | 2025-06-27 | 2025-06-27 | View Filing |
| 4 | 2025-06-23 | 2025-06-23 | View Filing |
| 8-K | 2025-05-22 | 2025-05-22 | View Filing |
| SC 13G/A | 2025-05-15 | 2025-05-15 | View Filing |
| 8-K | 2025-05-15 | 2025-05-15 | View Filing |
| 10-Q | 2025-05-15 | 2025-05-15 | View Filing |
| 4 | 2025-05-14 | 2025-05-14 | View Filing |
| 8-K | 2025-05-07 | 2025-05-07 | View Filing |
| 4 | 2025-05-01 | 2025-05-01 | View Filing |
| 4 | 2025-04-30 | 2025-04-30 | View Filing |
| 4 | 2025-04-30 | 2025-04-30 | View Filing |
| 3 | 2025-04-30 | 2025-04-30 | View Filing |
| 3 | 2025-04-30 | 2025-04-30 | View Filing |
| 8-K | 2025-04-08 | 2025-04-08 | View Filing |
| EFFECT | 2025-03-28 | 2025-03-28 | View Filing |
| SC 13G | 2025-03-25 | 2025-03-25 | View Filing |
| S-3/A | 2025-03-25 | 2025-03-25 | View Filing |
| S-3 | 2025-03-19 | 2025-03-19 | View Filing |
| 10-K | 2025-03-19 | 2025-03-19 | View Filing |
| 8-K | 2025-03-13 | 2025-03-13 | View Filing |
| 8-K | 2025-02-26 | 2025-02-26 | View Filing |
| 8-K | 2025-02-20 | 2025-02-20 | View Filing |
| SC 13G/A | 2025-02-14 | 2025-02-14 | View Filing |
| SC 13G/A | 2025-02-14 | 2025-02-14 | View Filing |
| 8-K | 2024-12-23 | 2024-12-23 | View Filing |
| 8-K | 2024-12-13 | 2024-12-13 | View Filing |
| 8-K | 2024-11-29 | 2024-11-29 | View Filing |
| DEFA14A | 2024-11-26 | 2024-11-26 | View Filing |
| 8-K | 2024-11-19 | 2024-11-19 | View Filing |
| 8-K | 2024-11-18 | 2024-11-18 | View Filing |
| SC 13G/A | 2024-11-14 | 2024-11-14 | View Filing |
| DEF 14A | 2024-11-14 | 2024-11-14 | View Filing |
| 10-Q | 2024-11-12 | 2024-11-12 | View Filing |
| 8-K | 2024-11-01 | 2024-11-01 | View Filing |
| 8-K | 2024-09-26 | 2024-09-26 | View Filing |
| 10-Q | 2024-08-13 | 2024-08-13 | View Filing |
| 8-K | 2024-08-06 | 2024-08-06 | View Filing |
| 8-K | 2024-07-11 | 2024-07-11 | View Filing |
| 424B5 | 2024-07-11 | 2024-07-11 | View Filing |
| 8-K | 2024-06-12 | 2024-06-12 | View Filing |
| 8-K | 2024-05-23 | 2024-05-23 | View Filing |
| 8-K | 2024-05-15 | 2024-05-15 | View Filing |
| 10-Q | 2024-05-13 | 2024-05-13 | View Filing |
| 8-K | 2024-04-30 | 2024-04-30 | View Filing |
| DEFN14A | 2024-04-16 | 2024-04-16 | View Filing |
| 8-K | 2024-04-12 | 2024-04-12 | View Filing |
| PRE 14A | 2024-04-05 | 2024-04-05 | View Filing |
| 8-K | 2024-04-04 | 2024-04-04 | View Filing |
| 424B5 | 2024-04-04 | 2024-04-03 | View Filing |
| SC 13G | 2024-04-01 | 2024-04-01 | View Filing |
| 424B5 | 2024-03-29 | 2024-03-29 | View Filing |
| 10-K | 2024-03-27 | 2024-03-27 | View Filing |
| 8-K | 2024-03-26 | 2024-03-26 | View Filing |
| 424B5 | 2024-03-26 | 2024-03-26 | View Filing |
| 424B5 | 2024-03-22 | 2024-03-22 | View Filing |
| 424B5 | 2024-03-22 | 2024-03-22 | View Filing |
Algorithm Performance
Upgrade To Premium for Full Access
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|---|---|---|---|---|---|
| Liquidity Sweep Strategy | 100.31% | 1.11 | 11 | 0.58 | 1.34 | 99.09 |
| Quantum Inspired Strategy | 72.20% | 1.07 | 16 | 0.43 | 0.59 | 70.99 |
| Adaptive Wave | 71.87% | 0.57 | 2 | 0.51 | 0.58 | 70.65 |
| xxxxxxxxxxxxxxxxxxxx | xxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxx | xxxxx |
| xxxxxxxxxxxxxxxxx | xxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxx | xxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxx | xxxx | x |
| xxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxx | x% | x | xx | x | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | xxxx | x | x | x | xxx |
| xxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxx |
| xxxxxxxxx | x% | x | xx | x | x | xxxx |
| xxx | x% | x | x | x | x | xxx |
| xxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxx | x% | x | x | xxxx | xxxx | xxx |
| xxxxxxxxxx | xxxxxxx% | x | xx | xxxxx | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxx | xxxxx% | xxxx | xx | xxxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxx | xxxxxxxx% | xxxx | xx | x | x | xxxxx |
| xxxxxxxxx | xxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxx | xxxxxx% | x | x | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxx | xxxxxxxx% | x | x | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | x | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | x | xxxxx | xxxx | xxxxx |